Latest coverage
News
Small Cap Stock news
Marizyme is Pleased to Announce the Appointment of David Barthel as CEO
[ad_1] JUPITER, Fla. – (NewMediaWire) – November 16, 2021 – Marizyme Inc. (“Marizyme” or the “Company”) (OTCQB:MRZM), is pleased to announce the hiring of Mr. David Barthel as the Chief Executive Officer for Marizyme. In his role Mr. Barthel will look to advance the Company’s technology pipeline and stay committed to the
Tauriga Sciences, Inc. Confirms the Commercial Launch of its New Kosher Certified by Orthodox Union
[ad_1] New York, NY – (NewMediaWire) – November 16, 2021 – Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a New York based diversified Life Sciences Company, today confirmed the commercial launch of its new & improved Tauri-Gummies™ product, Kosher Certified by Orthodox Union. This product has been successfully reformul
Hoth Therapeutics Announces a Sponsored Research Agreement to Further Develop Novel mRNA Cancer Therapeutic HT-KIT
NEW YORK, NY November 16, 2021/PR Newswire/ Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company, today announced that it has signed a Sponsored Research Agreement with North Carolina State University (“NC State”) to support the continued research and development of HT-KIT, a novel therapeutic for the treatment mast cell cance
Muscle Maker, Inc. Posts Another Triple Digit Revenue Increase in Q3, Improving Financial Results
Health-focused restaurant company experiences 190% revenue gains as the integration of recent acquisitions begins to be reported League City, Texas, November 16th, 2021 — Muscle Maker, Inc. (Nasdaq: GRIL) the parent company of Muscle Maker Grill, Pokemoto and Superfit Foods, today announced the posting of its third quarter 2021 financial results on Nov
BioElectronics Corporation Reports Q3 Earnings
[ad_1] Year over Year Revenue Growth Exceeds 463% FREDERICK, MARYLAND – (NewMediaWire) – November 16, 2021 – BioElectronics Corporation (https://www.bielcorp.com/ OTC: BIEL) announces a 463% increase in sales revenue resulting in a profitable 3rd quarter. Keeping in line with BIEL’s impressive year-over-year growth, the nine months ended
Todos Medical Reports Third Quarter 2021 Business and Financial Results
[ad_1] New York, NY, and Tel Aviv, ISRAEL – (NewMediaWire) – November 15, 2021 – Todos Medical, Ltd. (“Todos Medical”) (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, announced financial results today for the third quarter ended September 30, 2021. Corporate Highlights Integration of COVID-19 PCR automati
ABVC Biopharma Reports Third Quarter 2021 Financial and Operational Results
[ad_1] Fremont, CA – (NewMediaWire) – November 15, 2021 – ABVC BioPharma, Inc. (Nasdaq: ABVC), a biotechnology company specializing in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes, today announced its financial and operating results for the third quarter of 2021. Third Quarter 2021 Fi
Reliance Global Group Announces Successful Launch of 5MinuteInsure.com in Tennessee
[ad_1] Follows successful launch in MI, AZ, IN & OH; accelerating rollout to additional states in the near term Lakewood, NJ – (NewMediaWire) – November 15, 2021 – Reliance Global Group, Inc. (Nasdaq: RELI; RELIW), which combines AI and cloud-based technologies with the personalized experience of a traditional insurance agency, today announ
NanoViricides Completes Oral Gummies and Lung Inhalation Formulations Development for its Non-Mutagenic, Safe, Broad-Spectrum COVID-19 Clinical Drug Candidate, NV-CoV-2
Shelton, Connecticut — (November 15, 2021) – NanoViricides, Inc. (NYSE American: NNVC) (the "Company"), a leader in the development of highly effective antiviral therapies based on a novel nanomedicines technology, announced today that it has developed oral gummies formulations of its Pan-Coronavirus COVID-19 Drug Candidate NV-CoV-2 to benefit no
Adults with acute heart failure benefit when treated with a type 2 diabetes medication
[ad_1] Research Highlights: When treated with empagliflozin, adults hospitalized for acute heart failure were 36% more likely to have a clinical benefit, such as a reduction in all-cause mortality, reduction in heart failure events, or an improvement in heart failure symptoms. Empagliflozin was originally primarily prescribed for treating type 2 diabet
Stem cell therapy for heart failure reduced major CV events and death, not hospitalization
[ad_1] Research Highlights: Adults with chronic, class II or III heart failure with reduced ejection fraction (HFrEF), as defined by the New York Heart Association criteria, who were treated with stem cells experienced a 65% reduction in non-fatal heart attack or stroke events. In NYHA class II heart failure (HF) patients with high levels ...
Blood thinners may prevent cognitive decline in older patients with atrial fibrillation
[ad_1] Research Highlights: A randomized, multi-center, international trial found that when adequately used, prescribed at the correct dosage and taken appropriately by patients for two years, there was no difference between the anticoagulant medications dabigatran and warfarin in preventing cognitive decline. Oral anticoagulants – medications that pre
Repair of tricuspid valve leak during mitral valve surgery may benefit some adults
[ad_1] Research Highlights: A leak in the mitral valve can lead to leaking of the tricuspid valve. When the tricuspid leaking is severe, surgery to fix both valves at the same time generally occurs, however, there has been no consensus on whether the additional procedure should be done if the tricuspid leak is less than ...
Time from stopping blood thinner to bypass surgery may be shortened for select patients
[ad_1] Research Highlights: The medication ticagrelor is a common anti-platelet medication prescribed to prevent blood clotting after a heart attack. Because ticagrelor is a blood thinner, it should be stopped prior to surgery due to the risk of bleeding. Notably, 10% of patients with heart attacks require coronary artery bypass surgery. Current Americ
Village doctor-led intervention effective in BP control, adds health care access options
[ad_1] Research Highlights: High blood pressure is a leading, preventable risk factor for cardiovascular disease and death from all causes, yet many people in low- and middle-income countries do not have their blood pressure controlled to optimal levels, often because they don’t have access to health care. Community health workers who had some basic ..
3DX Accepts Bitcoin and Ethereum for Manufacturing Projects
[ad_1] Seattle – (NewMediaWire) – November 12, 2021 – 3DX Industries Inc. (DDDX) (the “Company” or “3DX”), a state of the art additive manufacturer specializing in 3D Metal Printing, announced it will start accepting Bitcoin and Ethereum as payment for manufacturing services via Coinbase. 3DX Industries, Inc. is once again pioneering the us
Dewmar International Announces the Public Availability of its Disclosure Document and its Financial Statement for the Period Ended September 30, 2021
[ad_1] New York, NY – (NewMediaWire) – November 12, 2021 – Dewmar International BMC Inc. announced today that its complete disclosure statements and financial reports for the period ended September 30, 2021 are available for download on its website. The file is not password protected and anyone can view the disclosure statements and financi
Society Pass (SoPa) Announces Closing of $26,000,000 Initial Public Offering and Closing of $2,125,000 Over-Allotment
[ad_1] Singapore – (NewMediaWire) – November 12, 2021 – Society Pass Incorporated (Nasdaq: SOPA) (“SoPa” or the “Company”), a leading Southeast Asian data-driven loyalty platform, today announced the closing of its initial public offering (the “IPO”) of 2,888,889 shares of its common stock (“Common Stock”) at a price of $9.00 per share and
AppSwarm Announces Agreement with Renavotio, Inc. (OTCQB:RIII) for Infrastructure and Smart City Development
[ad_1] Tulsa, OK – (NewMediaWire) – November 12, 2021 – AppSwarm, Corp. (OTC: SWRM), a software development company and aggregator of mobile applications, announces a memorandum of understanding (MOU) with Renavotio, Inc. (OTCQB: RIII), an infrastructure investment company focused on opportunities, including 5G, ISP, utility construction an
GeoVax Reports 2021 Third Quarter Financial Results and Provides Corporate Update
[ad_1] Progress in Clinical Development of COVID-19 and Immuno-Oncology Programs Atlanta, GA – (NewMediaWire) – November 11, 2021 – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against infectious diseases and cancers, today announced its financial results for the quarter ended September 3
Forian Inc. Announces Third Quarter Fiscal 2021 Financial Results
[ad_1] Third Quarter Revenue of $5.0 Million, Up $4.8 Million Year-Over-Year,Pro Forma Year-Over-Year Growth of 62% Newtown, PA – (NewMediaWire) – November 11, 2021 – Forian Inc. (NASDAQ: FORA), a provider of technology, analytics and data science driven solutions for the healthcare and cannabis industries, today announced results for the f
Hop-On, Inc., Acquires Vertuoso To Integrate Company's Expertise With Vertical Story-Telling Into Hop-On's Digitalage Platform
[ad_1] Temecula, CA – (NewMediaWire) – November 11, 2021 – Hop-on, Inc. (OTC:HPNN,) an international leader in the development and manufacture of electronics, software and telecommunications hardware, has announced its intention to acquire Vertuoso, an entertainment industry company specializing in vertical story-telling, ad-tech and conten
Pharmagreen Prepares for Entry Into the Multi-Billion Dollar California Cannabis Industry
[ad_1] CARSON CITY, NV – (NewMediaWire) – November 11, 2021 – Pharmagreen Biotech, Inc., (OTC PINKS: PHBI), is pleased to announce that in advance of its entry into the multi-billion dollar California cannabis industry and the development of its Tissue Culture Centre, the company has engaged its research and development corporate partner to
Xalles Joint Venture GioBot to Create SaaS Cryptocurrency Trading Solution
[ad_1] Washington, DC – (NewMediaWire) – November 10, 2021 – Xalles Holdings Inc. (OTC: XALL), a fintech holding company providing innovative technology and financial services solutions to capitalize on the growing cryptocurrency and digital asset market, today announced a joint venture between Xalles Capital Inc. and Aktary Enterprises LLC